bioAffinity Technologies (BIAFW) News Today $0.62 -0.02 (-3.11%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product DevelopmentNovember 5, 2024 | finance.yahoo.comSA company sets the stage for Asian expansionOctober 31, 2024 | bizjournals.combioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry GuidelinesOctober 16, 2024 | finance.yahoo.comBioAffinity Names Michael Edwards as Interim CFOAugust 24, 2024 | marketwatch.combioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFOAugust 24, 2024 | stockhouse.combioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung SalesAugust 14, 2024 | finance.yahoo.comBIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023April 2, 2024 | investorplace.combioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsApril 1, 2024 | finance.yahoo.combioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungMarch 5, 2024 | finance.yahoo.combioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsDecember 5, 2023 | finance.yahoo.combioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNovember 28, 2023 | finance.yahoo.combioAffinity Technologies files for a $25M mixed shelf offeringNovember 16, 2023 | msn.combioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceOctober 10, 2023 | finance.yahoo.combioAffinity Technologies Acquires Laboratory Assets of Precision Pathology ServicesSeptember 19, 2023 | finance.yahoo.combioAffinity Technologies Inc. WtSeptember 15, 2023 | wsj.combioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 14, 2023 | finance.yahoo.comAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerJuly 12, 2023 | finance.yahoo.combioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumJune 15, 2023 | finance.yahoo.combioAffinity Technologies Presents Research Findings at CYTO 2023May 22, 2023 | finance.yahoo.combioAffinity Technologies, Inc. Rings the Nasdaq Stock Market Closing BellApril 7, 2023 | nasdaq.combioAffinity Technologies, Inc. Rings the Closing BellApril 7, 2023 | nasdaq.comAfter launching IPO, promising SA biotech still chasing profitabilityApril 4, 2023 | bizjournals.combioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023March 24, 2023 | finance.yahoo.combioAffinity Technologies Appoints Julie Anne Overton Director of Corporate CommunicationsFebruary 13, 2023 | finance.yahoo.comBioAffinity Technologies Shares Rise 8% After Getting Notice to Allow U.S. PatentJanuary 4, 2023 | marketwatch.combioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO MeetingDecember 1, 2022 | finance.yahoo.combioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 14, 2022 | finance.yahoo.combioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory BoardNovember 10, 2022 | finance.yahoo.combioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and AustraliaOctober 25, 2022 | finance.yahoo.combioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST ConferenceOctober 12, 2022 | finance.yahoo.combioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6MSeptember 28, 2022 | finance.yahoo.combioAffinity Technologies, Inc. Warrant (BIAFW)September 27, 2022 | nasdaq.combioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONESeptember 14, 2022 | finance.yahoo.com Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report... The Next SpaceX Pre-IPO BIAFW Media Mentions By Week BIAFW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAFW News Sentiment▼0.000.46▲Average Medical News Sentiment BIAFW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAFW Articles This Week▼00▲BIAFW Articles Average Week Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MMA News Today AUUDW News Today DTSTW News Today XELAP News Today FTAIP News Today FTAIN News Today FTAIM News Today GRABW News Today SWVLW News Today BABA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAFW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
